Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Review

Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

	Abstract	Full	Pdf
Dec 2019	4	4	1
Jan 2020	10	10	2
Feb 2020	34	34	4
Mar 2020	31	31	10
Apr 2020	19	19	8
May 2020	38	38	7
Jun 2020	31	31	7
Jul 2020	35	35	17
Aug 2020	51	51	17
Sep 2020	53	53	15
Oct 2020	76	76	19
Nov 2020	77	77	24
Dec 2020	81	81	26
Jan 2021	95	95	29
Feb 2021	63	63	14
Mar 2021	103	103	18
Apr 2021	184	184	24
May 2021	83	83	19
Jun 2021	100	100	31
Jul 2021	76	76	13
Aug 2021	72	72	5
Sep 2021	79	79	7
Oct 2021	101	101	22
Nov 2021	70	70	4
Dec 2021	83	84	14
Jan 2022	81	85	7
Feb 2022	65	65	6
Mar 2022	61	63	11
Apr 2022	54	56	12
May 2022	49	51	6
Jun 2022	47	47	2
Jul 2022	39	45	10
Aug 2022	45	47	5
Sep 2022	47	48	2
Oct 2022	49	50	5
Nov 2022	52	55	12
Dec 2022	47	47	2
Jan 2023	32	32	5
Feb 2023	55	55	4
Mar 2023	51	52	6
Apr 2023	25	26	2
May 2023	37	37	10
Jun 2023	47	47	4
Jul 2023	37	37	8
Aug 2023	44	45	7
Sep 2023	26	27	7
Oct 2023	35	35	5
Nov 2023	37	38	9
Dec 2023	36	36	11
Jan 2024	18	19	6
Feb 2024	47	47	11
Mar 2024	39	39	22
Total	2851	2881	554